Applications — HPLCmart

Classification

Compound

Mode

More criteria

Column vendor

Length, mm

Int. diameter, mm

Particle size, μm

Pore size, Å

Found 4,302

Already have a column?

Column name

Showing 4,302 applications

Sort by:

ID	Classification	Compounds	Linked columns
PDF 2169	Drugs Pharmaceuticals	9 compounds 3-Methyl.4-nitrobenzoic acid Benzyl alcohol Hexanophenone Nortriptyline Phenol Pyridine Quinidine Sulfathiazole Triprolidine	Phenomenex Gemini-NX C18 150 × 4.6 mm · 5.0 µm
PDF 2168	Drugs Pharmaceuticals	10 compounds 3-Methyl.4-nitrobenzoic acid Benzyl alcohol Hexanophenone Methylsalicylaldehyde Nortriptyline Phenol Pyridine Quinidine Sulfathiazole Triprolidine	Phenomenex Gemini-NX C18 150 × 4.6 mm · 5.0 µm
PDF 2167	Alkaloids Biochemistry	1 compounds Nicotine	Phenomenex Gemini-NX C18 150 × 4.6 mm · 5.0 µm
PDF 2166	Alkaloids Biochemistry	1 compounds Nicotine	Phenomenex Gemini-NX C18 150 × 4.6 mm · 5.0 µm
PDF 2165	Drugs Pharmaceuticals	4 compounds Amitriptyline Clomipramine Imipramine Nortriptyline	Phenomenex Gemini-NX C18 150 × 4.6 mm · 5.0 µm
PDF 2164	Drugs Pharmaceuticals	9 compounds Alprenolol Atenolol Bisoprolol Labetolol diastereomers Metoprolol Nadolol Pindolol Propranolol Sotalol	Phenomenex Gemini-NX C18 150 × 4.6 mm · 5.0 µm
PDF 2163	Drugs Pharmaceuticals	5 compounds Acetaminophen Chlorpheniramine Dextromethorphan Maleic acid Phenylephrine	Phenomenex Gemini C18 150 × 4.6 mm · 5.0 µm
PDF 2162	Drugs Pharmaceuticals	2 compounds Diphenhydramine Propranolol	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2161	Antibiotics Pharmaceuticals	3 compounds Chlortetracycline Oxytetracycline Tetracycline	Phenomenex Gemini C18 150 × 3.0 mm · 5.0 µm
PDF 2160	Drugs Pharmaceuticals	1 compounds Ribavirin	Phenomenex Gemini C18 100 × 2.0 mm · 5.0 µm
PDF 2159	Opiates Pharmaceuticals	3 compounds Morphine Morphine-3-b-glucuronide Normorphine	Phenomenex Gemini C18 100 × 2.0 mm · 5.0 µm
PDF 2158	Biochemistry Metabolism	3 compounds Cotinine Nicotine Nornicotine	Phenomenex Gemini C18 100 × 2.0 mm · 5.0 µm
PDF 2157	Not classified	1 compounds Bemethan	Phenomenex Gemini C18 100 × 2.0 mm · 5.0 µm
PDF 2156	Drugs Pharmaceuticals	3 compounds Amitriptyline Naproxen Toluene	Phenomenex Gemini-NX C18 150 × 4.6 mm · 5.0 µm
PDF 2155	Drugs Pharmaceuticals	3 compounds Amitriptyline Naproxen Toluene	Phenomenex Gemini-NX C18 150 × 4.6 mm · 5.0 µm
PDF 2154	Drugs Pharmaceuticals	3 compounds Amitriptyline Naproxen Toluene	Phenomenex Gemini-NX C18 150 × 4.6 mm · 5.0 µm
PDF 2153	Drugs Pharmaceuticals	3 compounds Amitriptyline Naproxen Toluene	Phenomenex Gemini-NX C18 150 × 4.6 mm · 5.0 µm
PDF 2152	Drugs Pharmaceuticals	5 compounds Acetaminophen Chlorpheniramine Dextromethorphan Maleic acid Phenylephrine	Phenomenex Gemini C18 150 × 4.6 mm · 5.0 µm
PDF 2151	Drugs Pharmaceuticals	2 compounds Diphenhydramine Propranolol	Phenomenex Gemini C18 50 × 21.2 mm · 5.0 µm
PDF 2150	Drugs Pharmaceuticals	3 compounds Diphenhydramine Oxybutynin Terfenadine	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2149	Drugs Pharmaceuticals	3 compounds Diphenhydramine Oxybutynin Terfenadine	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2148	Drugs Pharmaceuticals	3 compounds Diphenhydramine Oxybutynin Terfenadine	Phenomenex Gemini C18 50 × 21.2 mm · 5.0 µm
PDF 2147	Biochemistry Metabolism	7 compounds Anhydroerythromycin A Erythromycin A Erythromycin A enol ether Erythromycin B Erythromycin C Erythromycin F Pseudo-erythromycin A enol ether	Phenomenex Gemini-NX C18 250 × 4.6 mm · 5.0 µm
PDF 2146	Drugs Pharmaceuticals	5 compounds Sulfamerazine Sulfamethoxazole Sulfanilamide Sulfaquinoloxaline Sulfathiazole	Phenomenex Gemini C18 150 × 3.0 mm · 5.0 µm
PDF 2145	Antibiotics Pharmaceuticals	5 compounds Chlortetracycline Doxycycline Methacycline Oxytetracycline Tetracycline	Phenomenex Gemini C18 50 × 4.6 mm · 5.0 µm
PDF 2144	Drugs Pharmaceuticals	3 compounds Diphenhydramine Doxylamine Scopalamine	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 2143	Biochemistry Metabolism	7 compounds 1'(R)-2'(S)-cis-Nicotine-N'-oxide 1'(S)-2'(S)-trans-Nicotine-N'-oxide Cotinine Cotinine-N'-oxide Hydroxycotinine Nicotine Picric Acid	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 2142	Drugs Pharmaceuticals	5 compounds Ethylparaben Ibuprofen Indomethacin Indoprofen Naproxen	Phenomenex Synergi Polar-RP 150 × 4.6 mm · 4.0 µm
PDF 2141	Biochemistry Organic acids	2 compounds Acetic acid Formic acid	Phenomenex Synergi Polar-RP 150 × 4.6 mm · 4.0 µm
PDF 2140	Antibiotics Pharmaceuticals	7 compounds Ampicillin chloramphenicol Cloxacillin Florfenicol Flunixin Penicillin G Thiamphenicol	Phenomenex Gemini C18 50 × 2.0 mm · 3.0 µm
PDF 2139	Drugs Pharmaceuticals	3 compounds Diphenhydramine Oxybutynin Terfenadine	Phenomenex Gemini C18 50 × 21.2 mm · 5.0 µm
PDF 2138	Drugs Pharmaceuticals	2 compounds Diphenhydramine Lidocaine	Phenomenex Gemini C18 50 × 21.2 mm · 5.0 µm
PDF 2137	Drugs Pharmaceuticals	2 compounds Diphenhydramine Lidocaine	Phenomenex Gemini C18 50 × 21.2 mm · 5.0 µm
PDF 2136	Drugs Pharmaceuticals	2 compounds Diphenhydramine Lidocaine	Phenomenex Gemini C18 50 × 21.2 mm · 5.0 µm
PDF 2135	Drugs Pharmaceuticals	2 compounds Diphenhydramine Lidocaine	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2134	Drugs Pharmaceuticals	2 compounds Diphenhydramine Lidocaine	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2133	Drugs Pharmaceuticals	3 compounds Diphenhydramine Oxybutynin Terfenadine	Phenomenex Gemini C18 50 × 21.2 mm · 5.0 µm
PDF 2132	Drugs Pharmaceuticals	8 compounds Sulfadiazine Sulfadimethoxine Sulfamerazine Sulfamethazine Sulfamethoxazole Sulfapyridine Sulfaquinoxaline Sulfathiazole	Phenomenex Gemini C18 50 × 4.6 mm · 3.0 µm
PDF 2131	Drugs Pharmaceuticals	3 compounds Cimetidine Famotidine Ranitidine	Phenomenex Synergi Polar-RP 150 × 4.6 mm · 4.0 µm
PDF 2130	Drugs Pharmaceuticals	3 compounds Diphenhydramine Oxybutynin Terfenadine	Phenomenex Gemini-NX C18 50 × 21.2 mm · 5.0 µm
PDF 2129	Pharmaceuticals Steroids	3 compounds Estradiol Estrone Ethylparaben	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 2128	Drugs Pharmaceuticals	1 compounds Ranitidine	Phenomenex Synergi Polar-RP 150 × 4.6 mm · 4.0 µm
PDF 2127	Drugs Pharmaceuticals	1 compounds Ranitidine	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 2126	Drugs Pharmaceuticals	1 compounds Cimetidine	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 2125	Drugs Pharmaceuticals	1 compounds Famotidine	Phenomenex Synergi Max-RP 150 × 4.6 mm · 4.0 µm
PDF 2124	Drugs Pharmaceuticals	6 compounds Chlorpheniramine Codeine Desipramine Ibuprofen Propranolol Thiourea	Phenomenex Synergi Max-RP 50 × 4.6 mm · 4.0 µm
PDF 2123	Drugs Pharmaceuticals	6 compounds Chlorpheniramine Codeine Desipramine Ibuprofen Propranolol Thiourea	Phenomenex Synergi Max-RP 50 × 4.6 mm · 4.0 µm
PDF 2122	Drugs Pharmaceuticals	6 compounds Chlorpheniramine Codeine Desipramine Ibuprofen Propranolol Thiourea	Phenomenex Synergi Max-RP 50 × 4.6 mm · 4.0 µm
PDF 2121	Drugs Pharmaceuticals	6 compounds Chlorpheniramine Codeine Desipramine Ibuprofen Propranolol Thiourea	Phenomenex Synergi Max-RP 50 × 4.6 mm · 4.0 µm
PDF 2120	Drugs Pharmaceuticals	4 compounds Methylparaben Phenylephrine Phenylpropanolamine Pseudoephedrine	Phenomenex Synergi Polar-RP 150 × 4.6 mm · 4.0 µm

Showing 2,201–2,250 of 4,302

← Prev3738394041424344454647484950515253Next page →